Eden puts an actual clinician on video, which is rarer here than it should be, and pairs that with 503A compounding so doses can be prepared in custom increments. Both are real advantages, and if what you have missed most is talking to a person, Eden offers it.
The conversation, though, is about weight. There is no gynecologic or whole-person framing in the published model, so the live access — the thing you are paying extra for — is spent on a consultation that does not have room for the rest of your history.
Here is how Eden reads against each promise of the Whole-Woman Charter. Each promise is marked none, partial or strong; price is shown but is never part of the rating. GLP-1 medications are not a treatment for endometriosis.
What Eden’s published price covers, taken from its own pages and checked October 2026. “Not listed on their site” means we could not find it published.
The plan includes video consultation and 503A titration at one published price across every dose, with no separate membership fee. On delivery quality this is a better model than most asynchronous services at similar money. The Charter still scores the first three rows at zero because it measures whether care is built to see the whole person, and Eden publishes nothing in that direction. Dose fit and human help sit at partial; cost scores strong because the number is readable before you commit.
Eden's pricing is now among the simplest on this page: the same monthly figure whether you are on a starting dose or a higher one. That clarity is worth crediting. What it buys, though, is a weight consultation. The low price does not change the fact that your endometriosis history has no obvious place in the visit, so the value depends on whether that context is already held somewhere else.
Put these to Eden in writing, and keep the reply.
Eden delivers a competent conventional weight service with genuine live contact and one of the clearest prices here, and it rates low only because this Charter measures something Eden does not attempt. If your endometriosis care is solid elsewhere and you want video access at a predictable cost, it is a reasonable choice.
What is above comes from what this provider chooses to publish, and providers revise their terms without saying so — treat it as a starting point and check it yourself. Havelle is editorial, not clinical: none of this is medical advice, and GLP-1 medications are not a treatment for endometriosis.